4.7 Article

Evaluation of Interactions between SARS-CoV-2 RBD and Full-Length ACE2 with Coarse-Grained Molecular Dynamics Simulations

Journal

JOURNAL OF CHEMICAL INFORMATION AND MODELING
Volume 62, Issue 4, Pages 936-944

Publisher

AMER CHEMICAL SOC
DOI: 10.1021/acs.jcim.1c01306

Keywords

-

Funding

  1. National Key Research and Development Program of China [2017YFA0104302]
  2. National Natural Science Foundation of China [51832001, 61821002, 11572087, 21903002]

Ask authors/readers for more resources

Coarse-grained models allow for the investigation of simulation system dynamics on a larger scale and longer time scale, making them suitable for studying macromolecular systems. In this work, coarse-grained molecular dynamics simulations were performed to reveal the interaction details between SARS-CoV-2 RBD and ACE2. The results provide insights into the binding process and potential drug targets for combating SARS-CoV-2.
Compared to all-atom models, coarse-grained models enable the investigation of the dynamics of simulation systems on a much larger length scale and a longer time scale, which makes them suitable for studying macromolecular systems. Hence, in this work, we performed multiple mu s-scale Martini coarse-grained molecular dynamics simulations to reveal the interaction details between SARS-CoV-2 RBD and full-length human ACE2. Besides, the key coarse-grained systems were backmapped into the corresponding all-atom system for the display of structural details. Our results indicated that the plier structure in two ends of the binding interface plays a key role in the binding process of SARS-CoV-2 RBD with ACE2. Furthermore, we also found that when there is no B0AT1 in the simulation system, the N-terminus of ACE2 is more likely to approach the cell membrane, which has a strong correlation with the subsequent fusion of the virus with the cell membrane. These binding details of SARS-CoV-2 RBD and the ACE2 protease domain (PD) as well as the membrane orientation thermodynamics can promote the development of therapeutic drugs and preventive vaccines against SARS-CoV-2.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available